Section Arrow
Quote
LMAT.NASDAQ
- LeMaitre Vascular
Quotes are at least 15-min delayed:2025/11/14 23:10 EST
Regular Hours
Last
 88.44
-1.2 (-1.34%)
Day High 
89.74 
Prev. Close
89.64 
1-M High
92.25 
Volume 
109.10K 
Bid
88.19
Ask
89.01
Day Low
87.73 
Open
89.74 
1-M Low
81.57 
Market Cap 
2.03B 
Currency USD 
P/E 38.64 
%Yield 1.09 
10-SMA 87.73 
20-SMA 88.35 
50-SMA 89.09 
52-W High 109.58 
52-W Low 71.42 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.32/2.62
Enterprise Value
2.22B
Balance Sheet
Book Value Per Share
16.70
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
219.86M
Operating Revenue Per Share
8.18
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed：2025/11/14 23:10 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.